A committee of outside clinical trial observers has recommended that Praxis Precision Medicines stop testing its experimental treatment for essential tremor after an interim analysis of one study ...
Older adults with essential tremor have a higher burden of mild cognitive impairment and dementia than the general population.
Praxis Precision Medicines isn’t letting a midphase fail stand in the way of its plans in essential tremor. While its selective T-type calcium channel blocker failed to beat placebo on the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results